[144] nVent Electric plc SEC Filing

Rhea-AI Filing Summary

nVent Electric plc (NVT) disclosed a proposed sale of 24,534 common shares to be executed through Fidelity Brokerage Services LLC on the NYSE. The filing lists an aggregate market value of $2,208,060.00 and states the company has 160,947,295 shares outstanding, with an approximate sale date of 08/12/2025.

The securities to be sold were acquired under stock options granted on 01/02/2020 (14,534 shares) and 03/01/2021 (10,000 shares) and the filing indicates cash as the form of payment. The filer reports no sales in the past three months and includes the standard representation that they do not possess undisclosed material adverse information about the issuer.

Insights

Financial Analyst

TL;DR: Small, disclosed insider sale via broker; unlikely to be material given the outstanding share count.

The Form 144 notifies the market of a planned sale of 24,534 common shares valued at $2,208,060 to be executed through Fidelity on the NYSE. The shares were acquired under options granted in 2020 and 2021 and are to be paid for in cash. Relative to the issuer's stated 160,947,295 shares outstanding, this quantity represents a very small fraction of the float. The filing follows procedural requirements and reports no prior sales in the past three months, reducing the likelihood of immediate market impact.

Corporate Governance Expert

TL;DR: Disclosure meets Rule 144 reporting expectations; document contains standard representations and no unusual terms.

The notice specifies the broker, exchange, acquisition type (stock options), and cash payment, providing clear traceability of the proposed sale. The filer also affirms they are not aware of undisclosed material adverse information. There are no indications of aggregated prior sales or atypical settlement conditions in the filing text provided. From a governance and compliance standpoint, the form contains the expected statements for a Rule 144 notice.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	24534	2208060.00	160947295	08/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/12/2025	Option Granted - 01/02/2020	Issuer			14534	08/12/2025	Cash
Common	08/12/2025	Option Granted - 03/01/2021	Issuer			10000	08/12/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for NVT disclose?

It discloses a proposed sale of 24,534 common shares on the NYSE through Fidelity Brokerage Services with an aggregate market value of $2,208,060.00 and 160,947,295 shares outstanding.

How were the securities being sold acquired?

The securities were acquired under options: 14,534 shares from an option granted 01/02/2020 and 10,000 shares from an option granted 03/01/2021; payment at sale is cash.

Are there any reported sales by the filer in the past three months for NVT?

No. The filing states "Nothing to Report" for securities sold during the past three months.

Through which broker and exchange will the NVT shares be sold?

Fidelity Brokerage Services LLC is named as the broker and the sale is listed for the NYSE.

Does the filer state any undisclosed adverse information about the issuer?

The filer represents they do not know any material adverse information regarding the issuer that has not been publicly disclosed, per the filing's representation.